Consainsights logo

Tissue Ablation Market Size, Share, Industry Trends and Forecast to 2030

Tissue Ablation Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

Market Size & CAGR of Tissue Ablation Market in 2021

The global tissue ablation market had a market size of USD 4.5 billion in 2021 with a compound annual growth rate (CAGR) of 6.5%. This growth is attributed to the increasing prevalence of chronic diseases such as cancer, cardiac arrhythmia, and other conditions that require tissue ablation procedures for treatment.

COVID-19 Impact on the Tissue Ablation Market

The COVID-19 pandemic had a significant impact on the tissue ablation market in 2020 and 2021. The lockdowns and restrictions imposed to curb the spread of the virus led to a decrease in elective procedures, including tissue ablation surgeries. This resulted in a temporary slowdown in market growth.

However, with the easing of restrictions and healthcare systems adapting to the new normal, the tissue ablation market has started to recover. The focus on minimally invasive procedures and technological advancements in the field have contributed to the market's resilience in the face of the pandemic.

Tissue Ablation Dynamics

Tissue ablation involves the destruction of abnormal tissues using various energy sources such as radiofrequency, microwave, cryoablation, and others. The market dynamics are driven by the increasing prevalence of chronic diseases, advancements in ablation technologies, and the rising demand for minimally invasive procedures.

Furthermore, the growing geriatric population, which is more prone to conditions requiring tissue ablation, and the expanding healthcare infrastructure in developing countries are contributing to the growth of the tissue ablation market.

Segments and Related Analysis

By Technology:

- Radiofrequency Ablation

- Microwave Ablation

- Cryoablation

- Others

By Application:

- Cancer Treatment

- Cardiac Ablation

- Pain Management

- Others

By End User:

- Hospitals

- Ambulatory Surgical Centers

- Specialty Clinics

By Region Analysis

North America

The North American region dominated the tissue ablation market in 2021 due to the high prevalence of cancer and cardiac diseases, well-established healthcare infrastructure, and technological advancements in ablation procedures.

Europe

Europe is experiencing steady growth in the tissue ablation market, driven by the rising geriatric population, increasing awareness about minimally invasive procedures, and government initiatives to improve healthcare services.

Asia Pacific

The Asia Pacific region is witnessing rapid growth in the tissue ablation market due to the increasing incidence of cancer and cardiovascular diseases, expanding healthcare infrastructure, and adoption of advanced ablation technologies in countries like China, India, and Japan.

Latin America

Latin America is projected to show significant growth in the tissue ablation market, supported by the improving healthcare facilities, rising disposable income, and increasing focus on early disease detection and treatment.

Middle East and Africa

The Middle East and Africa region are also expected to witness growth in the tissue ablation market due to the increasing incidence of chronic diseases, government initiatives to enhance healthcare services, and investments in advanced medical technologies.

Key Market Players and Competitive Landscape

The key players in the tissue ablation market include Medtronic, Johnson & Johnson, Boston Scientific Corporation, Abbott Laboratories, and AngioDynamics, among others. These companies are focusing on product innovations, strategic collaborations, and acquisitions to strengthen their market position.

Recent Happenings in the Tissue Ablation Market

- In March 2021, Medtronic launched the OsteoCool RF Ablation System for the treatment of painful bone metastases, expanding its portfolio of tissue ablation devices.

- In November 2021, Johnson & Johnson acquired Mevion Medical Systems, a leader in proton therapy technology, to enhance its presence in the radiotherapy and tissue ablation market.

- In January 2022, Boston Scientific Corporation introduced the Vessix Renal Denervation System for the treatment of hypertension, showcasing its commitment to innovation in tissue ablation therapies.

- In April 2022, Abbott Laboratories announced the acquisition of Cardiome Pharma, a developer of cardiac ablation technologies, to expand its offerings in the tissue ablation market.

Frequently Asked Questions (FAQ):